BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morgan SA, McCabe EL, Gathercole LL, Hassan-Smith ZK, Larner DP, Bujalska IJ, Stewart PM, Tomlinson JW, Lavery GG. 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proc Natl Acad Sci U S A 2014;111:E2482-91. [PMID: 24889609 DOI: 10.1073/pnas.1323681111] [Cited by in Crossref: 151] [Cited by in F6Publishing: 134] [Article Influence: 18.9] [Reference Citation Analysis]
Number Citing Articles
1 Larner DP, Morgan SA, Gathercole LL, Doig CL, Guest P, Weston C, Hazeldine J, Tomlinson JW, Stewart PM, Lavery GG. Male 11β-HSD1 Knockout Mice Fed Trans-Fats and Fructose Are Not Protected From Metabolic Syndrome or Nonalcoholic Fatty Liver Disease. Endocrinology 2016;157:3493-504. [PMID: 27384305 DOI: 10.1210/en.2016-1357] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
2 Luo Y, Luo Y, Chang J, Xiao Z, Zhou B. Identification of candidate biomarkers and pathways associated with psoriasis using bioinformatics analysis. Hereditas 2020;157:30. [PMID: 32669126 DOI: 10.1186/s41065-020-00141-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Fine NHF, Doig CL, Elhassan YS, Vierra NC, Marchetti P, Bugliani M, Nano R, Piemonti L, Rutter GA, Jacobson DA, Lavery GG, Hodson DJ. Glucocorticoids Reprogram β-Cell Signaling to Preserve Insulin Secretion. Diabetes 2018;67:278-90. [PMID: 29203512 DOI: 10.2337/db16-1356] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
4 Mateus AP, Anjos L, Cardoso JR, Power DM. Chronic stress impairs the local immune response during cutaneous repair in gilthead sea bream (Sparus aurata, L.). Mol Immunol 2017;87:267-83. [PMID: 28521279 DOI: 10.1016/j.molimm.2017.04.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
5 Vogel F, Reincke M. Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess. Rev Endocr Metab Disord 2021. [PMID: 34241765 DOI: 10.1007/s11154-021-09670-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gali Ramamoorthy T, Begum G, Harno E, White A. Developmental programming of hypothalamic neuronal circuits: impact on energy balance control. Front Neurosci 2015;9:126. [PMID: 25954145 DOI: 10.3389/fnins.2015.00126] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
7 Gray GA, White CI, Castellan RF, McSweeney SJ, Chapman KE. Getting to the heart of intracellular glucocorticoid regeneration: 11β-HSD1 in the myocardium. J Mol Endocrinol 2017;58:R1-R13. [PMID: 27553202 DOI: 10.1530/JME-16-0128] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
8 Hardy RS, Zhou H, Seibel MJ, Cooper MS. Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy. Endocr Rev 2018;39:519-48. [PMID: 29905835 DOI: 10.1210/er.2018-00097] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 20.3] [Reference Citation Analysis]
9 Bird AD, Greatorex S, Reser D, Lavery GG, Cole TJ. Hydroxysteroid dehydrogenase HSD1L is localised to the pituitary-gonadal axis of primates. Endocr Connect 2017;6:489-99. [PMID: 28871060 DOI: 10.1530/EC-17-0119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
10 Brazel CB, Simon JC, Tuckermann JP, Saalbach A. Inhibition of 11β-HSD1 Expression by Insulin in Skin: Impact for Diabetic Wound Healing. J Clin Med 2020;9:E3878. [PMID: 33260645 DOI: 10.3390/jcm9123878] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Simunkova K, Duskova M, Kosak M, Krsek M, Hana V, Hill M, Jandikova H, Pospisilova H, Sramkova M, Bifulco E, Starka L. Response of Cortisol Metabolites in the Insulin Tolerance Test and Synacthen Tests. Physiol Res. [DOI: 10.33549/physiolres.933133] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Yang J, Chen Y, Li X, Xu D. New insights into the roles of glucocorticoid signaling dysregulation in pathological cardiac hypertrophy. Heart Fail Rev 2021. [PMID: 34455516 DOI: 10.1007/s10741-021-10158-x] [Reference Citation Analysis]
13 Shirif AZ, Kovačević S, Brkljačić J, Teofilović A, Elaković I, Djordjevic A, Matić G. Decreased Glucocorticoid Signaling Potentiates Lipid-Induced Inflammation and Contributes to Insulin Resistance in the Skeletal Muscle of Fructose-Fed Male Rats Exposed to Stress. Int J Mol Sci 2021;22:7206. [PMID: 34281257 DOI: 10.3390/ijms22137206] [Reference Citation Analysis]
14 Loerz C, Staab-weijnitz C, Huebbe P, Giller K, Metges C, Rimbach G, Maser E. Regulation of 11β-hydroxysteroid dehydrogenase type 1 following caloric restriction and re-feeding is species dependent. Chemico-Biological Interactions 2017;276:95-104. [DOI: 10.1016/j.cbi.2017.02.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Radhakutty A, Stranks JL, Mangelsdorf BL, Drake SM, Roberts GW, Zimmermann AT, Stranks SN, Thompson CH, Burt MG. Treatment of prednisolone-induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study. Diabetes Obes Metab 2017;19:571-8. [PMID: 27995731 DOI: 10.1111/dom.12859] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
16 Sakamuri A, Sakamuri SS, Kona SR, Jeyapal S, Ibrahim A. Diets with low n-6:n-3 PUFA ratio protects rats from fructose-induced dyslipidemia and associated hepatic changes: Comparison between 18:3 n-3 and long-chain n-3 PUFA. Prostaglandins, Leukotrienes and Essential Fatty Acids 2020;155:102082. [DOI: 10.1016/j.plefa.2020.102082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Lee SE, Lee EY, Kang SJ, Lee SH. 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Attenuates the Adverse Effects of Glucocorticoids on Dermal Papilla Cells. Yonsei Med J 2017;58:1204-10. [PMID: 29047245 DOI: 10.3349/ymj.2017.58.6.1204] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Li H, Sheng J, Wang J, Gao H, Yu J, Ding G, Ding N, He W, Zha J. Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice. Drug Des Devel Ther 2021;15:2309-24. [PMID: 34103895 DOI: 10.2147/DDDT.S285828] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ralph CR, Tilbrook AJ. INVITED REVIEW: The usefulness of measuring glucocorticoids for assessing animal welfare. J Anim Sci 2016;94:457-70. [PMID: 27065116 DOI: 10.2527/jas.2015-9645] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 9.7] [Reference Citation Analysis]
20 Dube S, Slama MQ, Basu A, Rizza RA, Basu R. Glucocorticoid Excess Increases Hepatic 11β-HSD-1 Activity in Humans: Implications in Steroid-Induced Diabetes. J Clin Endocrinol Metab 2015;100:4155-62. [PMID: 26308294 DOI: 10.1210/jc.2015-2673] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
21 Cooper MS, Seibel MJ, Zhou H. Glucocorticoids, bone and energy metabolism. Bone 2016;82:64-8. [PMID: 26051468 DOI: 10.1016/j.bone.2015.05.038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
22 Bigas J, Sevilla LM, Pérez P. Epidermal Mineralocorticoid Receptor Inactivation Affects the Homeostasis of All Skin Layers in Chronologically Aged Mice. J Invest Dermatol 2020;140:1899-908. [PMID: 32199993 DOI: 10.1016/j.jid.2020.03.933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Sefton C, Davies A, Allen TJ, Wray JR, Shoop R, Adamson A, Humphreys N, Coll AP, White A, Harno E. Metabolic Abnormalities of Chronic High-Dose Glucocorticoids Are Not Mediated by Hypothalamic AgRP in Male Mice. Endocrinology 2019;160:964-78. [PMID: 30794724 DOI: 10.1210/en.2019-00018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Liu L, Wang Y, Wang J, Dong Y, Chang S, Liu X, Lutfy K, Chen H, Friedman TC, Jiang M, Liu Y. Enhanced hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to diet-induced visceral adiposity. Int J Obes (Lond) 2018;42:1999-2011. [PMID: 29568102 DOI: 10.1038/s41366-018-0041-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
25 Loerz C, Maser E. The cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 in skeletal muscle in the pathogenesis of the metabolic syndrome. J Steroid Biochem Mol Biol 2017;174:65-71. [PMID: 28765040 DOI: 10.1016/j.jsbmb.2017.07.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
26 Zielinska AE, Fletcher RS, Sherlock M, Doig CL, Lavery GG. Cellular and genetic models of H6PDH and 11β-HSD1 function in skeletal muscle. Cell Biochem Funct 2017;35:269-77. [PMID: 28749080 DOI: 10.1002/cbf.3272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
27 Auer MK, Stalla GK, Stieg MR. Investigating the role of cortisol and growth hormone in fatty liver development: fatty liver index in patients with pituitary adenomas. Pituitary 2016;19:461-71. [PMID: 27194386 DOI: 10.1007/s11102-016-0726-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
28 Lee JH, Bok JH, Park SB, Pagire HS, Na Y, Rim E, Jung WH, Song JS, Kang NS, Seo HW, Jung K, Lee BH, Kim KY, Ahn JH. Optimization of cyclic sulfamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors for the potential treatment of ischemic brain injury. Bioorganic & Medicinal Chemistry Letters 2020;30:126787. [DOI: 10.1016/j.bmcl.2019.126787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ewald DA, Malajian D, Krueger JG, Workman CT, Wang T, Tian S, Litman T, Guttman-Yassky E, Suárez-Fariñas M. Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways. BMC Med Genomics 2015;8:60. [PMID: 26459294 DOI: 10.1186/s12920-015-0133-x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 74] [Article Influence: 10.7] [Reference Citation Analysis]
30 Turcu AF, Auchus RJ. Mild Adrenal Cortisol Excess. In: Geer EB, editor. The Hypothalamic-Pituitary-Adrenal Axis in Health and Disease. Cham: Springer International Publishing; 2017. pp. 181-97. [DOI: 10.1007/978-3-319-45950-9_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 Wu N, Katz DA, An G. A Target-Mediated Drug Disposition Model to Explain Nonlinear Pharmacokinetics of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor SPI-62 in Healthy Adults. J Clin Pharmacol 2021. [PMID: 34110620 DOI: 10.1002/jcph.1925] [Reference Citation Analysis]
32 Woods C, Tomlinson JW. The Dehydrogenase Hypothesis. In: Wang J, Harris C, editors. Glucocorticoid Signaling. New York: Springer; 2015. pp. 353-80. [DOI: 10.1007/978-1-4939-2895-8_16] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
33 Li J, Kennedy LJ, Walker SJ, Wang H, Li JJ, Hong Z, O'Connor SP, Ye XY, Chen S, Wu S, Yoon DS, Nayeem A, Camac DM, Ramamurthy V, Morin PE, Sheriff S, Wang M, Harper TW, Golla R, Seethala R, Harrity T, Ponticiello RP, Morgan NN, Taylor JR, Zebo R, Maxwell B, Moulin F, Gordon DA, Robl JA. Discovery of Clinical Candidate BMS-823778 as an Inhibitor of Human 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD-1). ACS Med Chem Lett 2018;9:1170-4. [PMID: 30613321 DOI: 10.1021/acsmedchemlett.8b00307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Morris MJ, Beilharz JE, Maniam J, Reichelt AC, Westbrook RF. Why is obesity such a problem in the 21st century? The intersection of palatable food, cues and reward pathways, stress, and cognition. Neuroscience & Biobehavioral Reviews 2015;58:36-45. [DOI: 10.1016/j.neubiorev.2014.12.002] [Cited by in Crossref: 136] [Cited by in F6Publishing: 121] [Article Influence: 19.4] [Reference Citation Analysis]
35 Muroya S, Zhang Y, Otomaru K, Oshima K, Oshima I, Sano M, Roh S, Ojima K, Gotoh T. Maternal Nutrient Restriction Disrupts Gene Expression and Metabolites Associated with Urea Cycle, Steroid Synthesis, Glucose Homeostasis, and Glucuronidation in Fetal Calf Liver. Metabolites 2022;12:203. [DOI: 10.3390/metabo12030203] [Reference Citation Analysis]
36 Kamwa V, Welch C, Hassan-Smith ZK. The endocrinology of sarcopenia and frailty. Minerva Endocrinol (Torino) 2021;46:453-68. [PMID: 33331737 DOI: 10.23736/S0391-1977.20.03198-3] [Reference Citation Analysis]
37 Woods CP, Hazlehurst JM, Tomlinson JW. Glucocorticoids and non-alcoholic fatty liver disease. J Steroid Biochem Mol Biol. 2015;154:94-103. [PMID: 26241028 DOI: 10.1016/j.jsbmb.2015.07.020] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 10.6] [Reference Citation Analysis]
38 Hardy RS, Doig CL, Hussain Z, O'Leary M, Morgan SA, Pearson MJ, Naylor A, Jones SW, Filer A, Stewart PM, Buckley CD, Lavery GG, Cooper MS, Raza K. 11β-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation. J Pathol 2016;240:472-83. [PMID: 27578244 DOI: 10.1002/path.4806] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
39 Finik J, Buthmann J, Zhang W, Go K, Nomura Y. Placental Gene Expression and Offspring Temperament Trajectories: Predicting Negative Affect in Early Childhood. J Abnorm Child Psychol 2020;48:783-95. [PMID: 32185610 DOI: 10.1007/s10802-020-00632-9] [Reference Citation Analysis]
40 Randall MJ, Kostin SF, Burgess EJ, Hoyt LR, Ather JL, Lundblad LK, Poynter ME. Anti-inflammatory effects of levalbuterol-induced 11β-hydroxysteroid dehydrogenase type 1 activity in airway epithelial cells. Front Endocrinol (Lausanne) 2014;5:236. [PMID: 25628603 DOI: 10.3389/fendo.2014.00236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Gomez-Sanchez EP, Gomez-Sanchez CE. 11β-hydroxysteroid dehydrogenases: A growing multi-tasking family. Mol Cell Endocrinol 2021;526:111210. [PMID: 33607268 DOI: 10.1016/j.mce.2021.111210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
42 Dhaliwal A, Williams FR, Quinlan JI, Allen SL, Greig C, Filer A, Raza K, Ghosh S, Lavery GG, Newsome PN, Choudhary S, Breen L, Armstrong MJ, Elsharkawy AM, Lord JM. Evaluation of the mechanisms of sarcopenia in chronic inflammatory disease: protocol for a prospective cohort study. Skelet Muscle 2021;11:27. [PMID: 34895316 DOI: 10.1186/s13395-021-00282-5] [Reference Citation Analysis]
43 Coutinho AE, Kipari TM, Zhang Z, Esteves CL, Lucas CD, Gilmour JS, Webster SP, Walker BR, Hughes J, Savill JS, Seckl JR, Rossi AG, Chapman KE. 11β-Hydroxysteroid Dehydrogenase Type 1 Is Expressed in Neutrophils and Restrains an Inflammatory Response in Male Mice. Endocrinology 2016;157:2928-36. [PMID: 27145012 DOI: 10.1210/en.2016-1118] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
44 Nikolaou N, Arvaniti A, Appanna N, Sharp A, Hughes BA, Digweed D, Whitaker MJ, Ross R, Arlt W, Penning TM, Morris K, George S, Keevil BG, Hodson L, Gathercole LL, Tomlinson JW. Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo. J Endocrinol 2020;245:207-18. [PMID: 32106090 DOI: 10.1530/JOE-19-0473] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Spaanderman DCE, Nixon M, Buurstede JC, Sips HHCM, Schilperoort M, Kuipers EN, Backer EA, Kooijman S, Rensen PCN, Homer NZM, Walker BR, Meijer OC, Kroon J. Androgens modulate glucocorticoid receptor activity in adipose tissue and liver. Journal of Endocrinology 2019;240:51-63. [DOI: 10.1530/joe-18-0503] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
46 Chuanxin Z, Shengzheng W, Lei D, Duoli X, Jin L, Fuzeng R, Aiping L, Ge Z. Progress in 11β-HSD1 inhibitors for the treatment of metabolic diseases: A comprehensive guide to their chemical structure diversity in drug development. Eur J Med Chem 2020;191:112134. [PMID: 32088493 DOI: 10.1016/j.ejmech.2020.112134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Venneri MA, Hasenmajer V, Fiore D, Sbardella E, Pofi R, Graziadio C, Gianfrilli D, Pivonello C, Negri M, Naro F, Grossman AB, Lenzi A, Pivonello R, Isidori AM. Circadian Rhythm of Glucocorticoid Administration Entrains Clock Genes in Immune Cells: A DREAM Trial Ancillary Study. J Clin Endocrinol Metab 2018;103:2998-3009. [PMID: 29846607 DOI: 10.1210/jc.2018-00346] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
48 Zheng Z, Seo H, Kwak HJ, Kim KY, Ahn JH, Bae MA, Song JS. Pharmacokinetic characterization of 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone, a novel 11β-hydroxysteroid dehydrogenase type 1 inhibitor in rats. Arch Pharm Res 2016;39:492-8. [PMID: 26780247 DOI: 10.1007/s12272-015-0702-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Panigrahi SK, Toedesbusch CD, McLeland JS, Lucey BP, Wardlaw SL. Diurnal Patterns for Cortisol, Cortisone and Agouti-Related Protein in Human Cerebrospinal Fluid and Blood. J Clin Endocrinol Metab 2020;105:dgz274. [PMID: 31838496 DOI: 10.1210/clinem/dgz274] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
50 Cobice DF, Livingstone DEW, McBride A, MacKay CL, Walker BR, Webster SP, Andrew R. Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice. Biochem Pharmacol 2018;148:88-99. [PMID: 29248595 DOI: 10.1016/j.bcp.2017.12.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
51 Petrus P, Rosqvist F, Edholm D, Mejhert N, Arner P, Dahlman I, Rydén M, Sundbom M, Risérus U. Saturated fatty acids in human visceral adipose tissue are associated with increased 11- β-hydroxysteroid-dehydrogenase type 1 expression. Lipids Health Dis 2015;14:42. [PMID: 25934644 DOI: 10.1186/s12944-015-0042-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
52 Dunford EC, Riddell MC. The Metabolic Implications of Glucocorticoids in a High-Fat Diet Setting and the Counter-Effects of Exercise. Metabolites 2016;6:E44. [PMID: 27929385 DOI: 10.3390/metabo6040044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
53 Martin CS, Cooper MS, Hardy RS. Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe. Front Endocrinol (Lausanne) 2021;12:733611. [PMID: 34512556 DOI: 10.3389/fendo.2021.733611] [Reference Citation Analysis]
54 Vojnović Milutinović D, Teofilović A, Veličković N, Brkljačić J, Jelača S, Djordjevic A, Macut D. Glucocorticoid signaling and lipid metabolism disturbances in the liver of rats treated with 5α-dihydrotestosterone in an animal model of polycystic ovary syndrome. Endocrine 2021;72:562-72. [PMID: 33449293 DOI: 10.1007/s12020-020-02600-1] [Reference Citation Analysis]
55 Morgan SA, Hassan-Smith ZK, Doig CL, Sherlock M, Stewart PM, Lavery GG. Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism. J Endocrinol 2016;229:277-86. [PMID: 27048233 DOI: 10.1530/JOE-16-0011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
56 Baudrand R, Vaidya A. Cortisol dysregulation in obesity-related metabolic disorders. Curr Opin Endocrinol Diabetes Obes 2015;22:143-9. [PMID: 25871955 DOI: 10.1097/MED.0000000000000152] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
57 Dey S, Scullen T, Noguchi CT. Erythropoietin negatively regulates pituitary ACTH secretion. Brain Res 2015;1608:14-20. [PMID: 25765155 DOI: 10.1016/j.brainres.2015.02.052] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
58 Cinti S. Adipose Organ Development and Remodeling. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1357-431. [DOI: 10.1002/cphy.c170042] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 10.8] [Reference Citation Analysis]
59 Infante M, Armani A, Mammi C, Fabbri A, Caprio M. Impact of Adrenal Steroids on Regulation of Adipose Tissue. Compr Physiol 2017;7:1425-47. [PMID: 28915330 DOI: 10.1002/cphy.c160037] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
60 Nikolaou N, Gathercole LL, Kirkwood L, Dunford JE, Hughes BA, Gilligan LC, Oppermann U, Penning TM, Arlt W, Hodson L, Tomlinson JW. AKR1D1 regulates glucocorticoid availability and glucocorticoid receptor activation in human hepatoma cells. J Steroid Biochem Mol Biol 2019;189:218-27. [PMID: 30769091 DOI: 10.1016/j.jsbmb.2019.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
61 Xie X, Xiao Q, Xiong Z, Yu C, Zhou J, Fu Z. Crocin-I ameliorates the disruption of lipid metabolism and dysbiosis of the gut microbiota induced by chronic corticosterone in mice. Food Funct 2019;10:6779-91. [PMID: 31576875 DOI: 10.1039/c9fo01533g] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
62 Rahimi L, Rajpal A, Ismail-Beigi F. Glucocorticoid-Induced Fatty Liver Disease. Diabetes Metab Syndr Obes 2020;13:1133-45. [PMID: 32368109 DOI: 10.2147/DMSO.S247379] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
63 Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Endocr Rev 2016;37:467-520. [PMID: 27459230 DOI: 10.1210/er.2015-1104] [Cited by in Crossref: 334] [Cited by in F6Publishing: 293] [Article Influence: 55.7] [Reference Citation Analysis]
64 Clayton SA, Jones SW, Kurowska-Stolarska M, Clark AR. The role of microRNAs in glucocorticoid action. J Biol Chem 2018;293:1865-74. [PMID: 29301941 DOI: 10.1074/jbc.R117.000366] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 7.3] [Reference Citation Analysis]
65 Hart KA, Wochele DM, Norton NA, McFarlane D, Wooldridge AA, Frank N. Effect of Age, Season, Body Condition, and Endocrine Status on Serum Free Cortisol Fraction and Insulin Concentration in Horses. J Vet Intern Med 2016;30:653-63. [PMID: 26860336 DOI: 10.1111/jvim.13839] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
66 Peng K, Pan Y, Li J, Khan Z, Fan M, Yin H, Tong C, Zhao Y, Liang G, Zheng C. 11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes. Sci Rep 2016;6:37160. [PMID: 27841334 DOI: 10.1038/srep37160] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
67 Hochberg I, Harvey I, Tran QT, Stephenson EJ, Barkan AL, Saltiel AR, Chandler WF, Bridges D. Gene expression changes in subcutaneous adipose tissue due to Cushing's disease. J Mol Endocrinol 2015;55:81-94. [PMID: 26150553 DOI: 10.1530/JME-15-0119] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
68 Anderson AJ, Andrew R, Homer NZM, Hughes KA, Boyle LD, Nixon M, Karpe F, Stimson RH, Walker BR. Effects of Obesity and Insulin on Tissue-Specific Recycling Between Cortisol and Cortisone in Men. J Clin Endocrinol Metab 2021;106:e1206-20. [PMID: 33270115 DOI: 10.1210/clinem/dgaa896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Ferraù F, Korbonits M. Metabolic comorbidities in Cushing's syndrome. Eur J Endocrinol 2015;173:M133-57. [PMID: 26060052 DOI: 10.1530/EJE-15-0354] [Cited by in Crossref: 79] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
70 Doig CL, Fletcher RS, Morgan SA, McCabe EL, Larner DP, Tomlinson JW, Stewart PM, Philp A, Lavery GG. 11β-HSD1 Modulates the Set Point of Brown Adipose Tissue Response to Glucocorticoids in Male Mice. Endocrinology 2017;158:1964-76. [PMID: 28368470 DOI: 10.1210/en.2016-1722] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
71 Resende ATP, Martins CS, Bueno AC, Moreira AC, Foss-Freitas MC, de Castro M. Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2. Clin Endocrinol (Oxf) 2019;91:94-103. [PMID: 30954027 DOI: 10.1111/cen.13984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
72 Bailey MA. 11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome. Curr Hypertens Rep 2017;19:100. [PMID: 29138984 DOI: 10.1007/s11906-017-0797-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
73 Takaya J. Calcium-Deficiency during Pregnancy Affects Insulin Resistance in Offspring. Int J Mol Sci 2021;22:7008. [PMID: 34209784 DOI: 10.3390/ijms22137008] [Reference Citation Analysis]
74 Kang SW, Kidd MT Jr, Kadhim HJ, Shouse S, Orlowski SK, Hiltz J, Anthony NB, Kuenzel WJ, Kong BC. Characterization of stress response involved in chicken myopathy. Gen Comp Endocrinol 2020;295:113526. [PMID: 32540490 DOI: 10.1016/j.ygcen.2020.113526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
75 Oda S, Ashida K, Uchiyama M, Sakamoto S, Hasuzawa N, Nagayama A, Wang L, Nagata H, Sakamoto R, Kishimoto J, Todaka K, Ogawa Y, Nakanishi Y, Nomura M. An open-label phase Ⅰ/Ⅱ a clinical trial of 11β-HSD1 inhibitor for Cushing's syndrome and autonomous cortisol secretion. J Clin Endocrinol Metab 2021:dgab450. [PMID: 34143883 DOI: 10.1210/clinem/dgab450] [Reference Citation Analysis]
76 Harasim-Symbor E, Konstantynowicz-Nowicka K, Chabowski A. Additive effects of dexamethasone and palmitate on hepatic lipid accumulation and secretion. J Mol Endocrinol 2016;57:261-73. [PMID: 27707773 DOI: 10.1530/JME-16-0108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
77 Bergmann TK, Isbel NM, Ostini R, Barraclough KA, Campbell SB, McWhinney BC, Inder WJ, Russell A, Staatz CE. Exploratory study of total and free prednisolone plasma exposure and cushingoid appearance, quality of life and biochemical toxicity in adult male kidney transplant recipients. Clin Drug Investig 2015;35:743-50. [PMID: 26403249 DOI: 10.1007/s40261-015-0334-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
78 Gariani K, Jornayvaz FR. Pathophysiology of NASH in endocrine diseases. Endocr Connect 2021;10:R52-65. [PMID: 33449917 DOI: 10.1530/EC-20-0490] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
79 Manolopoulos KN, O'Reilly MW, Bujalska IJ, Tomlinson JW, Arlt W. Acute Hypercortisolemia Exerts Depot-Specific Effects on Abdominal and Femoral Adipose Tissue Function. J Clin Endocrinol Metab 2017;102:1091-101. [PMID: 28323916 DOI: 10.1210/jc.2016-3600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
80 Hardy RS, Botfield H, Markey K, Mitchell JL, Alimajstorovic Z, Westgate CSJ, Sagmeister M, Fairclough RJ, Ottridge RS, Yiangou A, Storbeck KH, Taylor AE, Gilligan LC, Arlt W, Stewart PM, Tomlinson JW, Mollan SP, Lavery GG, Sinclair AJ. 11βHSD1 Inhibition with AZD4017 Improves Lipid Profiles and Lean Muscle Mass in Idiopathic Intracranial Hypertension. J Clin Endocrinol Metab 2021;106:174-87. [PMID: 33098644 DOI: 10.1210/clinem/dgaa766] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
81 Harvey I, Stephenson EJ, Redd JR, Tran QT, Hochberg I, Qi N, Bridges D. Glucocorticoid-Induced Metabolic Disturbances Are Exacerbated in Obese Male Mice. Endocrinology 2018;159:2275-87. [PMID: 29659785 DOI: 10.1210/en.2018-00147] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
82 Kline SA, Mega MS. Stress-Induced Neurodegeneration: The Potential for Coping as Neuroprotective Therapy. Am J Alzheimers Dis Other Demen 2020;35:153331752096087. [DOI: 10.1177/1533317520960873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
83 Zou X, Ramachandran P, Kendall TJ, Pellicoro A, Dora E, Aucott RL, Manwani K, Man TY, Chapman KE, Henderson NC, Forbes SJ, Webster SP, Iredale JP, Walker BR, Michailidou Z. 11Beta-hydroxysteroid dehydrogenase-1 deficiency or inhibition enhances hepatic myofibroblast activation in murine liver fibrosis. Hepatology 2018;67:2167-81. [PMID: 29251794 DOI: 10.1002/hep.29734] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
84 Hill JL, Solomon MB, Nguyen ET, Caldwell JL, Wei Y, Foster MT. Glucocorticoids regulate adipose tissue protein concentration in a depot- and sex-specific manner. Stress 2020;23:243-7. [PMID: 31441358 DOI: 10.1080/10253890.2019.1658736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
85 Hunter RW, Bailey MA. Glucocorticoids and 11β-hydroxysteroid dehydrogenases: mechanisms for hypertension. Current Opinion in Pharmacology 2015;21:105-14. [DOI: 10.1016/j.coph.2015.01.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
86 Fenton CG, Doig CL, Fareed S, Naylor A, Morrell AP, Addison O, Wehmeyer C, Buckley CD, Cooper MS, Lavery GG, Raza K, Hardy RS. 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy. Arthritis Res Ther 2019;21:188. [PMID: 31420008 DOI: 10.1186/s13075-019-1972-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
87 Spiers JG, Chen HJ, Cuffe JS, Sernia C, Lavidis NA. Acute restraint stress induces rapid changes in central redox status and protective antioxidant genes in rats. Psychoneuroendocrinology 2016;67:104-12. [PMID: 26881836 DOI: 10.1016/j.psyneuen.2016.02.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
88 Legeza B, Marcolongo P, Gamberucci A, Varga V, Bánhegyi G, Benedetti A, Odermatt A. Fructose, Glucocorticoids and Adipose Tissue: Implications for the Metabolic Syndrome. Nutrients 2017;9:E426. [PMID: 28445389 DOI: 10.3390/nu9050426] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
89 Nieman LK. Update on subclinical Cushingʼs syndrome: . Current Opinion in Endocrinology & Diabetes and Obesity 2015;22:180-4. [DOI: 10.1097/med.0000000000000159] [Cited by in Crossref: 24] [Cited by in F6Publishing: 3] [Article Influence: 3.4] [Reference Citation Analysis]
90 Gong J, Hansen L, Iacono L. Clinical Pharmacokinetics and the Impact of Genetic Polymorphism on a CYP2C19 Substrate, BMS-823778, in Healthy Subjects. Drug Metab Dispos 2018;46:316-25. [DOI: 10.1124/dmd.117.078824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
91 Morgan SA, Hassan-Smith ZK, Lavery GG. MECHANISMS IN ENDOCRINOLOGY: Tissue-specific activation of cortisol in Cushing's syndrome. Eur J Endocrinol 2016;175:R83-9. [PMID: 26957494 DOI: 10.1530/EJE-15-1237] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
92 Diz-chaves Y, Gil-lozano M, Toba L, Fandiño J, Ogando H, González-matías LC, Mallo F. Stressing diabetes? The hidden links between insulinotropic peptides and the HPA axis. Journal of Endocrinology 2016;230:R77-94. [DOI: 10.1530/joe-16-0118] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
93 McManus B, Korpela R, O'Connor P, Schellekens H, Cryan JF, Cotter PD, Nilaweera KN. Compared to casein, bovine lactoferrin reduces plasma leptin and corticosterone and affects hypothalamic gene expression without altering weight gain or fat mass in high fat diet fed C57/BL6J mice. Nutr Metab (Lond) 2015;12:53. [PMID: 26649066 DOI: 10.1186/s12986-015-0049-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
94 Molnár Á, Kövesdi A, Szücs N, Tóth M, Igaz P, Rácz K, Patócs A. Polymorphisms of the GR and HSD11B1 genes influence body mass index and weight gain during hormone replacement treatment in patients with Addison's disease. Clin Endocrinol 2016;85:180-8. [DOI: 10.1111/cen.13022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
95 Bunte K, Smith DJ, Chappell MJ, Hassan-Smith ZK, Tomlinson JW, Arlt W, Tiňo P. Learning pharmacokinetic models for in vivo glucocorticoid activation. J Theor Biol 2018;455:222-31. [PMID: 30048717 DOI: 10.1016/j.jtbi.2018.07.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
96 Martins CS, Elias D, Colli LM, Couri CE, Souza MC, Moreira AC, Foss MC, Elias LL, de Castro M. HPA axis dysregulation, NR3C1 polymorphisms and glucocorticoid receptor isoforms imbalance in metabolic syndrome. Diabetes Metab Res Rev 2017;33. [PMID: 27507764 DOI: 10.1002/dmrr.2842] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
97 Webster JM, Kempen LJAP, Hardy RS, Langen RCJ. Inflammation and Skeletal Muscle Wasting During Cachexia. Front Physiol 2020;11:597675. [PMID: 33329046 DOI: 10.3389/fphys.2020.597675] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
98 Karnia MJ, Myślińska D, Dzik KP, Flis DJ, Podlacha M, Kaczor JJ. BST Stimulation Induces Atrophy and Changes in Aerobic Energy Metabolism in Rat Skeletal Muscles-The Biphasic Action of Endogenous Glucocorticoids. Int J Mol Sci 2020;21:E2787. [PMID: 32316389 DOI: 10.3390/ijms21082787] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
99 Sefton C, Harno E, Davies A, Small H, Allen TJ, Wray JR, Lawrence CB, Coll AP, White A. Elevated Hypothalamic Glucocorticoid Levels Are Associated With Obesity and Hyperphagia in Male Mice. Endocrinology 2016;157:4257-65. [PMID: 27649090 DOI: 10.1210/en.2016-1571] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
100 Hu Y, Sun Q, Zong Y, Liu J, Idriss AA, Omer NA, Zhao R. Prenatal betaine exposure alleviates corticosterone-induced inhibition of CYP27A1 expression in the liver of juvenile chickens associated with its promoter DNA methylation. Gen Comp Endocrinol 2017;246:241-8. [PMID: 28039067 DOI: 10.1016/j.ygcen.2016.12.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
101 Martins CS, de Castro M. Generalized and tissue specific glucocorticoid resistance. Mol Cell Endocrinol 2021;530:111277. [PMID: 33864884 DOI: 10.1016/j.mce.2021.111277] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
102 El-Sonbaty YA, Suddek GM, Megahed N, Gameil NM. Protocatechuic acid exhibits hepatoprotective, vasculoprotective, antioxidant and insulin-like effects in dexamethasone-induced insulin-resistant rats. Biochimie 2019;167:119-34. [PMID: 31557503 DOI: 10.1016/j.biochi.2019.09.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
103 Fenton C, Martin C, Jones R, Croft A, Campos J, Naylor AJ, Taylor AE, Chimen M, Cooper M, Lavery GG, Raza K, Hardy RS. Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids. Ann Rheum Dis 2021;80:250-60. [PMID: 33162397 DOI: 10.1136/annrheumdis-2020-218493] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
104 Gawlik A, Shmoish M, Hartmann MF, Malecka-tendera E, Wudy SA, Hochberg Z. Steroid Metabolomic Disease Signature of Nonsyndromic Childhood Obesity. The Journal of Clinical Endocrinology & Metabolism 2016;101:4329-37. [DOI: 10.1210/jc.2016-1754] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
105 Tiganescu A, Hupe M, Jiang YJ, Celli A, Uchida Y, Mauro TM, Bikle DD, Elias PM, Holleran WM. UVB induces epidermal 11β-hydroxysteroid dehydrogenase type 1 activity in vivo. Exp Dermatol 2015;24:370-6. [PMID: 25739654 DOI: 10.1111/exd.12682] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
106 Sagmeister MS, Taylor AE, Fenton A, Wall NA, Chanouzas D, Nightingale PG, Ferro CJ, Arlt W, Cockwell P, Hardy RS, Harper L. Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional study. Clin Endocrinol (Oxf) 2019;90:241-9. [PMID: 30358903 DOI: 10.1111/cen.13889] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
107 Murphy MO, Herald JB, Leachman J, Villasante Tezanos A, Cohn DM, Loria AS. A model of neglect during postnatal life heightens obesity-induced hypertension and is linked to a greater metabolic compromise in female mice. Int J Obes (Lond) 2018;42:1354-65. [PMID: 29535450 DOI: 10.1038/s41366-018-0035-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
108 Wang J, Wang Y, Liu L, Lutfy K, Friedman TC, Liu Y, Jiang M, Liu Y. Lack of adipose-specific hexose-6-phosphate dehydrogenase causes inactivation of adipose glucocorticoids and improves metabolic phenotype in mice. Clin Sci (Lond) 2019;133:2189-202. [PMID: 31696216 DOI: 10.1042/CS20190679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Hardy RS, Fenton C, Croft AP, Naylor AJ, Begum R, Desanti G, Buckley CD, Lavery G, Cooper MS, Raza K. 11 Beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis. J Autoimmun 2018;92:104-13. [PMID: 29891135 DOI: 10.1016/j.jaut.2018.05.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
110 Green BB, Armstrong DA, Lesseur C, Paquette AG, Guerin DJ, Kwan LE, Marsit CJ. The Role of Placental 11-Beta Hydroxysteroid Dehydrogenase Type 1 and Type 2 Methylation on Gene Expression and Infant Birth Weight. Biol Reprod 2015;92:149. [PMID: 25788665 DOI: 10.1095/biolreprod.115.128066] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
111 Murphy MO, Herald JB, Wills CT, Unfried SG, Cohn DM, Loria AS. Postnatal treatment with metyrapone attenuates the effects of diet-induced obesity in female rats exposed to early-life stress. Am J Physiol Endocrinol Metab 2017;312:E98-E108. [PMID: 27965205 DOI: 10.1152/ajpendo.00308.2016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
112 Gianotti L, Belcastro S, D’agnano S, Tassone F. The Stress Axis in Obesity and Diabetes Mellitus: An Update. Endocrines 2021;2:334-47. [DOI: 10.3390/endocrines2030031] [Reference Citation Analysis]
113 Zou C, Li W, Pan Y, Khan ZA, Li J, Wu X, Wang Y, Deng L, Liang G, Zhao Y. 11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity. Oncotarget 2017;8:96263-75. [PMID: 29221204 DOI: 10.18632/oncotarget.22015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
114 Nishiyama M, Iwasaki Y, Nakayama S, Okazaki M, Taguchi T, Tsuda M, Makino S, Fujimoto S, Terada Y. Tissue-Specific Regulation of 11β Hydroxysteroid Dehydrogenase Type-1 mRNA Expressions in Cushing's Syndrome Mouse Model. Steroids 2022;:109021. [PMID: 35339573 DOI: 10.1016/j.steroids.2022.109021] [Reference Citation Analysis]
115 Sai S, Esteves C, Kelly V, Sakaguchi K, McAndrew R, Chudleigh S, Spence A, Gibson B, Thomas A, Chapman KE. Reciprocal Regulation of HSD11B1 and HSD11B2 Predicts Glucocorticoid Sensitivity in Childhood Acute Lymphoblastic Leukemia. J Pediatr 2020;220:249-53. [PMID: 31987650 DOI: 10.1016/j.jpeds.2019.12.054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 Hu Y, Sun Q, Liu J, Jia Y, Cai D, Idriss AA, Omer NA, Zhao R. In ovo injection of betaine alleviates corticosterone-induced fatty liver in chickens through epigenetic modifications. Sci Rep 2017;7:40251. [PMID: 28059170 DOI: 10.1038/srep40251] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
117 Chiodini I, Gennari L. Grand Challenge in Adrenal Endocrinology: Is the Legacy of the Past a Challenge for the Future of Precision Medicine? Front Endocrinol (Lausanne) 2021;12:747006. [PMID: 34539585 DOI: 10.3389/fendo.2021.747006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 de Jong MC, Patel N, Hassan-Smith Z, Mihai R, Khan S. Sarcopenia is Associated with Reduced Survival following Surgery for Adrenocortical Carcinoma. Endocr Res 2021;:1-10. [PMID: 34340645 DOI: 10.1080/07435800.2021.1954942] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Jing J, Sun J, Wu Y, Zhang N, Liu C, Chen S, Li W, Hong C, Xu B, Chen M. AQP9 Is a Prognostic Factor for Kidney Cancer and a Promising Indicator for M2 TAM Polarization and CD8+ T-Cell Recruitment. Front Oncol 2021;11:770565. [PMID: 34804972 DOI: 10.3389/fonc.2021.770565] [Reference Citation Analysis]
120 Musso G, Cassader M, Cohney S, Pinach S, Saba F, Gambino R. Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease. Trends Mol Med. 2015;21:645-662. [PMID: 26432021 DOI: 10.1016/j.molmed.2015.08.005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 9.3] [Reference Citation Analysis]
121 Vandermosten L, De Geest C, Knoops S, Thijs G, Chapman KE, De Bosscher K, Opdenakker G, Van den Steen PE. 11β-hydroxysteroid dehydrogenase type 1 has no effect on survival during experimental malaria but affects parasitemia in a parasite strain-specific manner. Sci Rep 2017;7:13835. [PMID: 29062028 DOI: 10.1038/s41598-017-14288-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
122 Verma M, Kipari TMJ, Zhang Z, Man TY, Forster T, Homer NZM, Seckl JR, Holmes MC, Chapman KE. 11β-hydroxysteroid dehydrogenase-1 deficiency alters brain energy metabolism in acute systemic inflammation. Brain Behav Immun 2018;69:223-34. [PMID: 29162555 DOI: 10.1016/j.bbi.2017.11.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
123 Wang Q, Liu K, Feng B, Zhang Z, Wang R, Tang L, Li W, Li Q, Piferrer F, Shao C. Transcriptome of Gonads From High Temperature Induced Sex Reversal During Sex Determination and Differentiation in Chinese Tongue Sole, Cynoglossus semilaevis. Front Genet 2019;10:1128. [PMID: 31824559 DOI: 10.3389/fgene.2019.01128] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
124 Pullen TJ, Huising MO, Rutter GA. Analysis of Purified Pancreatic Islet Beta and Alpha Cell Transcriptomes Reveals 11β-Hydroxysteroid Dehydrogenase (Hsd11b1) as a Novel Disallowed Gene. Front Genet 2017;8:41. [PMID: 28443133 DOI: 10.3389/fgene.2017.00041] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
125 Jin G, He R, Sha B, Li W, Qing H, Teng R, Xu F. Electrospun three-dimensional aligned nanofibrous scaffolds for tissue engineering. Materials Science and Engineering: C 2018;92:995-1005. [DOI: 10.1016/j.msec.2018.06.065] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 12.5] [Reference Citation Analysis]
126 Cao J, Gao L, Chen Y, Sun W, Wang F, Li H, Zhang Y. Citrinal B, natural 11 beta-hydroxysteroid dehydrogennase type 1 inhibitor identified from structure-based virtual screening. Fitoterapia 2017;123:29-34. [DOI: 10.1016/j.fitote.2017.09.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
127 Fichna M, Żurawek M, Gryczyńska M, Sowińska A, Nowak J, Ruchała M. Polymorphic variants of the HSD11B1 gene may be involved in adverse metabolic effects of glucocorticoid replacement therapy in Addison's disease. European Journal of Internal Medicine 2016;31:99-104. [DOI: 10.1016/j.ejim.2016.03.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
128 Sherlock M, Behan LA, Hannon MJ, Alonso AA, Thompson CJ, Murray RD, Crabtree N, Hughes BA, Arlt W, Agha A, Toogood AA, Stewart PM. The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure. European Journal of Endocrinology 2015;173:583-93. [DOI: 10.1530/eje-15-0490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
129 Webster JM, Fenton CG, Langen R, Hardy RS. Exploring the Interface between Inflammatory and Therapeutic Glucocorticoid Induced Bone and Muscle Loss. Int J Mol Sci 2019;20:E5768. [PMID: 31744114 DOI: 10.3390/ijms20225768] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
130 Tiganescu A, Hupe M, Uchida Y, Mauro T, Elias PM, Holleran WM. Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice. Endocrinology 2018;159:547-56. [PMID: 29087473 DOI: 10.1210/en.2017-00607] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
131 Luijten IHN, Cannon B, Nedergaard J. Glucocorticoids and Brown Adipose Tissue: Do glucocorticoids really inhibit thermogenesis? Mol Aspects Med 2019;68:42-59. [PMID: 31323252 DOI: 10.1016/j.mam.2019.07.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
132 Christensen TH, Bailey MA, Kenyon CJ, Jensen BL, Hunter RW. Sodium homeostasis is preserved in a global 11β-hydroxysteroid dehydrogenase type 1 knockout mouse model. Exp Physiol 2015;100:1362-78. [PMID: 26337786 DOI: 10.1113/EP085177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
133 Gong J, Iacono L, Iyer RA, Humphreys WG, Zheng M. Physiologically-based pharmacokinetic modelling of a CYP2C19 substrate, BMS-823778, utilizing pharmacogenetic data. Br J Clin Pharmacol 2018;84:1335-45. [PMID: 29469197 DOI: 10.1111/bcp.13565] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
134 Welch C, K Hassan-Smith Z, A Greig C, M Lord J, A Jackson T. Acute Sarcopenia Secondary to Hospitalisation - An Emerging Condition Affecting Older Adults. Aging Dis 2018;9:151-64. [PMID: 29392090 DOI: 10.14336/AD.2017.0315] [Cited by in Crossref: 72] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
135 de Theije CC, Schols AMWJ, Lamers WH, Ceelen JJM, van Gorp RH, Hermans JJR, Köhler SE, Langen RCJ. Glucocorticoid Receptor Signaling Impairs Protein Turnover Regulation in Hypoxia-Induced Muscle Atrophy in Male Mice. Endocrinology 2018;159:519-34. [DOI: 10.1210/en.2017-00603] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
136 Ju R, Wu W, Tang Q, Wu D, Xia Y, Wu J, Wang X. Association Analysis between the Polymorphisms of HSD11B1 and H6PD and Risk of Polycystic Ovary Syndrome in Chinese Population. PLoS One 2015;10:e0140326. [PMID: 26452272 DOI: 10.1371/journal.pone.0140326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
137 Fenton CG, Webster JM, Martin CS, Fareed S, Wehmeyer C, Mackie H, Jones R, Seabright AP, Lewis JW, Lai YC, Goodyear CS, Jones SW, Cooper MS, Lavery GG, Langen R, Raza K, Hardy RS. Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis. Arthritis Res Ther 2019;21:182. [PMID: 31370858 DOI: 10.1186/s13075-019-1962-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
138 Mir N, Chin SA, Riddell MC, Beaudry JL. Genomic and Non-Genomic Actions of Glucocorticoids on Adipose Tissue Lipid Metabolism. Int J Mol Sci 2021;22:8503. [PMID: 34445209 DOI: 10.3390/ijms22168503] [Reference Citation Analysis]
139 Webster JM, Sagmeister MS, Fenton CG, Seabright AP, Lai YC, Jones SW, Filer A, Cooper MS, Lavery GG, Raza K, Langen R, Hardy RS. Global Deletion of 11β-HSD1 Prevents Muscle Wasting Associated with Glucocorticoid Therapy in Polyarthritis. Int J Mol Sci 2021;22:7828. [PMID: 34360594 DOI: 10.3390/ijms22157828] [Reference Citation Analysis]
140 Itoi-Ochi S, Terao M, Murota H, Katayama I. Local corticosterone activation by 11β-hydroxysteroid dehydrogenase 1 in keratinocytes: the role in narrow-band UVB-induced dermatitis. Dermatoendocrinol 2016;8:e1119958. [PMID: 27195053 DOI: 10.1080/19381980.2015.1119958] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
141 Wang WS, Guo CM, Sun K. Cortisol Regeneration in the Fetal Membranes, A Coincidental or Requisite Event in Human Parturition? Front Physiol 2020;11:462. [PMID: 32523541 DOI: 10.3389/fphys.2020.00462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
142 Jung C, Greco S, Nguyen HH, Ho JT, Lewis JG, Torpy DJ, Inder WJ. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers. BMC Endocr Disord 2014;14:91. [PMID: 25425285 DOI: 10.1186/1472-6823-14-91] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
143 Beaupere C, Liboz A, Fève B, Blondeau B, Guillemain G. Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance. Int J Mol Sci 2021;22:E623. [PMID: 33435513 DOI: 10.3390/ijms22020623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]